Search - tctmd.com

Displaying 721 - 740 of 2728

Sort: Relevancy | Date

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Aortic Aneurysm Killed Soccer Journalist Grant Wahl, Wife Says

L.A. McKeown

December 14, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Yael L. Maxwell

December 06, 2022

News Daily News

Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks

L.A. McKeown

November 30, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

Shelley Wood

November 28, 2022

News Daily News

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

Michael O'Riordan

November 24, 2022

News Daily News

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

Todd Neale

November 16, 2022

News Daily News

New Risk Models Superior to Pretest Probability at Predicting CAD

Yael L. Maxwell

November 15, 2022

News Conference News AHA 2022

Mindfulness Could Combat Uncontrolled Hypertension: MB-BP

Yael L. Maxwell

November 14, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Shelley Wood

November 10, 2022

News Conference News AHA 2022

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

Michael O'Riordan

November 09, 2022

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

L.A. McKeown

November 09, 2022

News Conference News AHA 2022

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Todd Neale

November 09, 2022

News Conference News AHA 2022

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Caitlin E. Cox

November 08, 2022

Presentation AHA 2022

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Presenter: David E. Kandzari

November 07, 2022

News Conference News AHA 2022

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Michael O'Riordan

November 07, 2022

Advertisement

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Aortic Aneurysm Killed Soccer Journalist Grant Wahl, Wife Says

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Tricuspid Regurgitation After AF Diagnosis Is Common, Worsens Outcomes

Think Before You Shake: UK Biobank Data Link Added Salt to Long-term CVD Risks

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Big Gains in Function, QoL With Transcatheter TV Replacement: TRISCEND Registry

Greater Carotid Plaque Burden in Asthmatic Patients: MESA

Novel Aldosterone Synthase Inhibitor Drops BP: Top-line Phase II Results

New Risk Models Superior to Pretest Probability at Predicting CAD

Mindfulness Could Combat Uncontrolled Hypertension: MB-BP

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMI

Endothelin Receptor Antagonist Effective in Resistant Hypertension: PRECISION

China Rural Intervention Still Reaping BP Control Wins at 3 Years

SPYRAL HTN-ON MED Trial of Renal Denervation Misses Primary Endpoint

Four Drugs, One Pill: QUARTET USA Supports New Strategy for BP-Lowering

Renal Denervation in the Presence of Anti-Hypertensive Medications: Six-Month Results from the Randomized, Blinded, Sham-Controlled SPYRAL HTN – ON MED Trial

Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content